Pathstone Holdings »

Mirum Pharmaceuticals shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7M 22k 78.99

More positions owned by Pathstone Holdings

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Crowdstrike Hldgs Cl A (CRWD)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Scp Etf (IJR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Pathstone Holdings

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
Henderson Group
BlackRock
Vanguard Group
State Street Corporation
Eventide Asset Management
BVF
Novo A/S
Tang Capital Management
Citadel Advisors
Geode Capital Management
D. E. Shaw & Co
ClearBridge Advisors
Polar Capital Holdings
Wellington Management Company

View all funds holding Mirum Pharmaceuticals